SALVIA
Also known as Salvia GmbH
First-generation single family office of Helmut Jeggle in Holzkirchen near Munich (est. 2014); venture investor in deep-tech and science start-ups such as IQM, Group14 and Wingcopter.
USEFUL FOR Founders · Business owners seeking a long-term partner · Co-investors
Holzkirchen single family office of Helmut Jeggle (Salvia GmbH, HRB 214305 München). Not Salvia BioElectronics (Dutch medtech) and separate from the Strüngmann family office (Athos), where Jeggle was long a manager.
Family & background
- FAMILY
- Jeggle (Helmut Jeggle)
- HEADQUARTERS
- Holzkirchen, Germany
- FOUNDED
- 2014
- OUTSIDE CAPITAL
- No — own capital only
Investment approach
- GEOGRAPHY
- GermanyEuropeNorth America
- STAGES
- SeedSeries ASeries BGrowth
- ROUTES
- Companies (own capital)
- STRATEGIES
- Venture capitalDirect investments
Overview
Salvia GmbH is a first-generation single family office based in Holzkirchen near Munich, founded in 2014 by Helmut Jeggle. It started with traditional angel investments and has developed into an entrepreneurial venture capital investor focused on deep-tech and science start-ups. Its portfolio spans quantum computing (IQM), battery materials (Group14), delivery drones (Wingcopter), AI software (One Data) and biotech (Bambusa Therapeutics), with exits including BioNTech, Aldevron, Ganymed and Boxine (tonies).
Investment thesis
Identify, invest in and build sustainable companies in deep tech and science, addressing macro trends such as climate change and resource scarcity; act as independent investor and sparring partner to start-ups and grown-ups.
Holdings & investments (19)
- IQMNOTABLEDeep Tech · since 2019 · Merger with Real Asset Acquisition Corp. (SPAC) announced Feb 2026
- BioNTechNOTABLEBiotech & Life Sciences · since 2008 · IPO (2019)
- Climate & Energy · since 2023
- Climate & Energy · since 2022
- Deep Tech · since 2022
- Artificial Intelligence · since 2021
- HealthTech · since 2021 · Completed investment
- Biotech & Life Sciences · since 2020 · Acquired (Danaher, 2021)
- Consumer & E-commerce · since 2019 · SPAC listing (2021)
- Ganymed PharmaceuticalsBiotech & Life Sciences · since 2008 · Acquired (Astellas, 2016)
- Bambusa TherapeuticsBiotech & Life Sciences
- Zadient TechnologiesDeep Tech
- Climate & Energy
- Food & Agriculture
- Consumer & E-commerce
- Artificial Intelligence
- HealthTech
- Consumer & E-commerce
- Biotech & Life Sciences
People
Frequently asked questions
SALVIA is a single family office based in Holzkirchen, Germany, founded in 2014.
SALVIA invests on behalf of the Jeggle (Helmut Jeggle) family.
SALVIA invests its own capital into companies. Its stated asset mix includes venture capital and direct investments.
SALVIA invests at Seed, Series A, Series B and Growth stages in Deep Tech, Biotech & Life Sciences, Climate & Energy, Artificial Intelligence and HealthTech.
Key people at SALVIA include Helmut Jeggle (Founder & Managing Partner; Geschäftsführer), Cornelia Jeggle (Treasury; Geschäftsführerin), Fabian Arndt (Investment Manager) and Isabelle Müldner (Investment Manager).
SALVIA's holdings and investments include IQM, BioNTech, Bambusa Therapeutics, Group14 Technologies, One Data, Wingcopter, Zadient Technologies and InPlanet, among others.
The most recent publicly reported investment by SALVIA is InPlanet (EUR 4.3M seed round (with FoodLabs and pre-seed investors)), announced in Oct 2023.
No. SALVIA invests its own capital and does not raise money from outside investors.